Loading...
•
Mar 31, 2024
Zoetis Q1 2024 Earnings Report
Reported a revenue increase of 10% and a net income increase of 9% for Q1 2024.
Key Takeaways
Zoetis reported strong first-quarter results for 2024, with revenue reaching $2.2 billion, a 10% increase compared to the previous year. Net income also saw a rise, amounting to $599 million, or $1.31 per diluted share, marking a 9% increase. The company has updated its full-year revenue guidance to $9.050 - $9.200 billion and expects diluted EPS of $5.34 to $5.44 on a reported basis.
Revenue reached $2.2 billion, a 10% increase, with net income at $599 million, or $1.31 per diluted share, a 9% increase.
Operational revenue growth was 12%, and adjusted net income grew by 15%.
Adjusted net income was $634 million, or $1.38 per diluted share.
Full-year revenue guidance updated to $9.050 - $9.200 billion, with diluted EPS of $5.34 to $5.44 on a reported basis.
Zoetis
Zoetis
Zoetis Revenue by Segment
Zoetis Revenue by Geographic Location
Revenue by Segment
Companion Animal Revenue
CapyFin.comLivestock Revenue
CapyFin.comContract Mfg. & Human Health Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Zoetis is updating its full year reported 2024 guidance for foreign exchange, with an increase to operational growth due to inflation-related price increases in Argentina and the underlying strength in companion animal.
Positive Outlook
- Revenue between $9.050 billion to $9.200 billion (operational growth of 8.5% to 10.5%)
- Reported net income between $2.450 billion to $2.495 billion
- Adjusted net income between $2.620 billion to $2.670 billion (operational growth of 13% to 15%)
- Reported diluted EPS of $5.34 to $5.44
- Adjusted diluted EPS between $5.71 to $5.81
Revenue & Expenses
Visualization of income flow from segment revenue to net income